Other languages Cytosorbents Corporation

Equities

CTSO

US23283X2062

Real-time Estimate Cboe BZX Other stock markets 03:26:12 2024-04-19 pm EDT			5-day change	1st Jan Change
0.817 ^USD	+2.00%		-7.11%	-27.03%

Mar. 15	Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 14	Earnings Flash (CTSO) CYTOSORBENTS Reports Q4 Revenue $8.7M, vs. Street Est of $9.8M	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 15
Cytosorbents Corporation Reports Excellent Outcomes from A Groundbreaking Randomized Controlled Trial Using Cytosorb® Blood Purification During Heart Transplant, Recently Published in the European Society of Cardiology Journal, Esc Heart Failure	Jan. 17
S&P 500 ekes out meager gains, flirts with bull market confirmation	Dec. 28
Sector Update: Health Care Stocks Rise in Late Afternoon	Dec. 28
Top Midday Decliners	Dec. 28
Wall St inches higher as S&P 500 flirts with bull market confirmation	Dec. 28
US Stocks Holding on for Small Thursday Gains, Again Drifting Near Record Highs	Dec. 28
US Stocks Adding to Recent Gain Amid New Economic Data	Dec. 28
Borsa Usa in rialzo in vista di fine anno, focus su taglio tassi Fed	Dec. 28
US STOCKS -Wall Street edges higher as year end approaches, rate cuts in focus	Dec. 28
Sector Update: Health Care Stocks Steady Premarket Thursday	Dec. 28
Sector Update: Health Care	Dec. 28
Cytosorbents Says DrugSorb-ATR Study Misses Primary Effectiveness Endpoint; Shares Fall Pre-Bell	Dec. 28
Sector Update: Health Care Stocks Advance Thursday Afternoon	Dec. 28
Sector Update: Health Care	Dec. 28
Cytosorbents Corporation Provides Update on the Star-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation	Dec. 28
Cytosorbents Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Cytosorbents Reappoints Kathleen Bloch as Finance Chief	23-09-19
CytoSorbents Corporation Completes U.S. and Canadian Star-T Pivotal Trial	23-08-14
Cytosorbents Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cytosorbents Corporation

Equities

CTSO

US23283X2062

Other languages

Filters